Meet
Judit Illes

Judit Illes works with a variety of client types to design customized solutions for improving patient access to healthcare services and therapies, informed by evidence and insights.

As an experienced facilitator, she regularly brings together multi-disciplinary workgroups to develop best practices in clinical care and health services research projects. Judit is passionate about advancing innovation and system redesign to improve healthcare quality for patients and their caregivers, especially in dementia care.

Prior to joining Avalere, Judit served as a research consultant at Hearthstone Alzheimer Care for an NIH-funded study testing a non-pharmacological intervention for people with dementia. As a graduate student at Columbia University, Judit conducted research on the role of environmental design features in long-term care settings for delivering person-centered care.

Judit is a certified professional in Healthcare Quality. She has a law degree from McGill University and a master's in bioethics from Columbia University.

Authored Content


Today, Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association published appropriate use criteria (AUC) to guide the use of lumbar puncture (LP) and cerebrospinal fluid (CSF) analysis for use in the diagnosis of Alzheimer’s disease.

Tune in to our podcast series where guest presenters explore the value of the newly released Alzheimer’s Association appropriate use criteria for lumbar puncture and cerebral spinal fluid (CFS) testing in the diagnosis of Alzheimer’s disease. Dr. Steven Salloway, Director of Neurology and the Memory and Aging Program at Butler Hospital, discusses how the Alzheimer’s Association’s new appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer’s disease will be helpful to clinicians in the diagnostic process.

Tune into the second podcast in our series where Dr. Leslie Shaw, Professor of Pathology and Laboratory Medicine at the Pearlman School of Medicine at the University of Pennsylvania and Chair of the Workgroup that developed the Alzheimer’s Association’s appropriate use criteria for lumbar puncture and cerebral spinal fluid (CSF) testing in the diagnosis of Alzheimer’s disease, discusses how the Workgroup reviewed an extensive body of research on advances in CSF testing to develop the AUC.

Tune in to our podcast series as we explore the value of the newly released Alzheimer’s Association appropriate use criteria for lumbar puncture and cerebral spinal fluid (CFS) testing in the diagnosis of Alzheimer’s disease. We kick off this series with Dr. Maria Carillo, the Alzheimer Association’s Chief Science Officer and Dr. Jim Hendrix, Director of Global Science Initiatives.

The findings, published in The Journal of Endocrinology & Metabolism, will guide a pilot study to assess interventions to improve the identification and management of diabetes patients at high risk for hypoglycemia.

Avalere and Mental Health America (MHA) developed a white paper to describe the current state of quality of care for individuals with major depressive disorder (MDD), provide an evidence-based assessment of challenges, and highlight potential opportunities for quality improvement.